Xie, X.; Lee, J.; Fuson, J.A.; Liu, H.; Iwase, T.; Yun, K.; Margain, C.; Tripathy, D.; Ueno, N.T.
Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines. Biomedicines 2023, 11, 735.
https://doi.org/10.3390/biomedicines11030735
AMA Style
Xie X, Lee J, Fuson JA, Liu H, Iwase T, Yun K, Margain C, Tripathy D, Ueno NT.
Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines. Biomedicines. 2023; 11(3):735.
https://doi.org/10.3390/biomedicines11030735
Chicago/Turabian Style
Xie, Xuemei, Jangsoon Lee, Jon A. Fuson, Huey Liu, Toshiaki Iwase, Kyuson Yun, Cori Margain, Debu Tripathy, and Naoto T. Ueno.
2023. "Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines" Biomedicines 11, no. 3: 735.
https://doi.org/10.3390/biomedicines11030735
APA Style
Xie, X., Lee, J., Fuson, J. A., Liu, H., Iwase, T., Yun, K., Margain, C., Tripathy, D., & Ueno, N. T.
(2023). Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines. Biomedicines, 11(3), 735.
https://doi.org/10.3390/biomedicines11030735